1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. individuals with uncontrolled hypotension (systolic blood pressure \< 90 mmhg) or need for vasopressor/inotropic medication 5. individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by \>25% from baseline or urine output of \<0.5 ml/kg for 6 hours) 6. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. individuals with uncontrolled hypotension (systolic blood pressure \< 90 mmhg) or need for vasopressor/inotropic medication 5. individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by \>25% from baseline or urine output of \<0.5 ml/kg for 6 hours) 6. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

women who are pregnant, breast feeding, or planning to become pregnant during the study inability to take medications orally individuals with a known fish allergy or hypersensitivity reaction individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

women who are pregnant, breast feeding, or planning to become pregnant during the study inability to take medications orally individuals with a known fish allergy or hypersensitivity reaction individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 5. individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) 6. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 5. individuals with renal impairment this will be assessed by increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) 6. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient.

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. current use of antiretroviral agents 5. individuals with requirement of supplemental oxygen to maintain oxygen saturations >94% 6. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 7. individuals with renal impairment - this will be assessed by abnormalities in creatinine and glomerular filtration rate at screening as per the qi 8. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) 9. any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. current use of antiretroviral agents 5. individuals with requirement of supplemental oxygen to maintain oxygen saturations >94% 6. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 7. individuals with renal impairment - this will be assessed by abnormalities in creatinine and glomerular filtration rate at screening as per the qi 8. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) 9. any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. current use of antiretroviral agents 5. individuals with requirement of supplemental oxygen to maintain oxygen saturations >94% 6. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 7. individuals with renal impairment (increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) 8. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) 9. any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient

1. women who are pregnant, breast feeding, or planning to become pregnant during the study 2. inability to take medications orally 3. individuals with a known fish allergy or hypersensitivity reaction 4. current use of antiretroviral agents 5. individuals with requirement of supplemental oxygen to maintain oxygen saturations >94% 6. individuals with uncontrolled hypotension (systolic blood pressure < 90 mmhg) or need for vasopressor/inotropic medication 7. individuals with renal impairment (increase of creatinine by 50% from baseline, glomerular filtration rate reduction by >25% from baseline or urine output of <0.5 ml/kg for 6 hours) 8. individuals with gastrointestinal symptoms that require hospitalization (e.g. severe nausea, vomiting, diarrhea or/and abdominal pain) 9. any other condition, that, in the opinion of the qi, may adversely affect the patient's ability to complete the study or its measures or pose significant risk to the patient